![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 03, 2020 11:46:07 AM
My reading is that the current IPF / CC Phase 2 Trial being recruited in Australia/NZ is different and separate from the planned Phase 2b / 3 Multinational Trials.
Canada Will be involved, probably in a lead roll IMO, along with the USFDA for sure,. Novotech can bring Patients from the Philippines or other Asian/Pacific countries and as noted has offices worldwide and in the US. Dont know about their reach to S America, Brazil.
I noted that Dr Williams had connections to E Eu that were discussed as part of his portion of the original BTH/AGN deal.
My reply is my interpretation and speculations.
https://clinicaltrials.gov/ct2/results?cond=&term=Ifenprodil&cntry=&state=&city=&dist=
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM